Pressemelding -

Calanus® Oil approved by Health Canada

Health Canada´s Natural and Non-prescription Health Products Directorate (NNHPD) has approved Calanus® Oil as a Natural Health Product.


Tromsø, Norway, January 22nd 2019. Calanus® Oil, derived from the crustacean Calanus finmarchicus, is a unique, natural marine oil with a different composition and other benefits than traditional marine omega-3 products. Calanus® Oil enables dietary supplement companies to help people at risk of developing diabetes and other metabolic disorders.

“We are already present in the EU and US with Calanus® Oil, and we are excited to also being able to contribute to the public health in Canada,” says Jan Erik Olsen, Head of Sales & Marketing of Calanus® Oil. He continues: “We have extensive scientific documentation on Calanus® Oil already, and we are now planning focused clinical trials with the objective to apply for health claims within the metabolic health area. We are convinced that Calanus® Oil offers additional health benefits compared to other omega-3 products. Calanus® Oil also meets the increasing consumer demand for naturally pure and sustainable products.”

For more information, contact Jan Erik Olsen on phone +47 951 45 351 or e-mail: jan.erik.olsen@calanus.no.

Related links

Emner

  • Fiskeri

Kategorier

  • calanus oil
  • diabetes
  • canada
  • novel food

Calanus AS is a biomarine company pioneering the sustainable harvesting and utilization of the crustacean Calanus finmarchicus. This small pelagic zooplankter, with a life span of one year, is the most numerous animal species on the planet and represents the largest harvestable animal biomass on the Northern hemisphere.

Domiciled in Tromsø - Norway’s largest seafood port and the “Gateway to the Arctic” - Calanus As is firmly rooted in a community built on harvesting of seafood, and on research for sustainable management and utilization of marine resources.

Pressekontakt

Siv Katrin Ramskjell

Pressekontakt CEO +47 901 94 149

Relatert innhold